A CK1α Activator Penetrates the Brain, and Shows Efficacy Against Drug-Resistant Metastatic Medulloblastoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1319
Full Text
Open PDFAbstract
Available in full text
Date
November 28, 2018
Authors
Publisher
American Association for Cancer Research (AACR)